img

Global Biopharma Buffer Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biopharma Buffer Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
Biopharma Buffer report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharma Buffer market is projected to reach US$ 1068.2 million in 2029, increasing from US$ 841 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2029. Demand from Research Institution and Pharmaceutical Industry are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharma Buffer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Avantor
Alfa Aesar (Thermo Fisher)
Merck
Lonza
Bio-Rad
BD
GE Healthcare
Promega Corporation
Hamilton Company
XZL BIO-TECHNOLOGY
SRL
Segment by Type
Phosphates Type
Acetates Type
TRIS Type
Others

Segment by Application


Research Institution
Pharmaceutical Industry
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharma Buffer market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Biopharma Buffer, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Biopharma Buffer industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Biopharma Buffer in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Biopharma Buffer introduction, etc. Biopharma Buffer Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Biopharma Buffer market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Biopharma Buffer Market Overview
1.1 Biopharma Buffer Product Overview
1.2 Biopharma Buffer Market Segment by Type
1.2.1 Phosphates Type
1.2.2 Acetates Type
1.2.3 TRIS Type
1.2.4 Others
1.3 Global Biopharma Buffer Market Size by Type
1.3.1 Global Biopharma Buffer Market Size Overview by Type (2018-2029)
1.3.2 Global Biopharma Buffer Historic Market Size Review by Type (2018-2024)
1.3.3 Global Biopharma Buffer Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biopharma Buffer Sales Breakdown by Type (2018-2024)
1.4.2 Europe Biopharma Buffer Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Biopharma Buffer Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Biopharma Buffer Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Biopharma Buffer Sales Breakdown by Type (2018-2024)
2 Global Biopharma Buffer Market Competition by Company
2.1 Global Top Players by Biopharma Buffer Sales (2018-2024)
2.2 Global Top Players by Biopharma Buffer Revenue (2018-2024)
2.3 Global Top Players by Biopharma Buffer Price (2018-2024)
2.4 Global Top Manufacturers Biopharma Buffer Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biopharma Buffer Market Competitive Situation and Trends
2.5.1 Biopharma Buffer Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Biopharma Buffer Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharma Buffer as of 2022)
2.7 Date of Key Manufacturers Enter into Biopharma Buffer Market
2.8 Key Manufacturers Biopharma Buffer Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biopharma Buffer Status and Outlook by Region
3.1 Global Biopharma Buffer Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Biopharma Buffer Historic Market Size by Region
3.2.1 Global Biopharma Buffer Sales in Volume by Region (2018-2024)
3.2.2 Global Biopharma Buffer Sales in Value by Region (2018-2024)
3.2.3 Global Biopharma Buffer Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Biopharma Buffer Forecasted Market Size by Region
3.3.1 Global Biopharma Buffer Sales in Volume by Region (2024-2029)
3.3.2 Global Biopharma Buffer Sales in Value by Region (2024-2029)
3.3.3 Global Biopharma Buffer Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Biopharma Buffer by Application
4.1 Biopharma Buffer Market Segment by Application
4.1.1 Research Institution
4.1.2 Pharmaceutical Industry
4.1.3 Others
4.2 Global Biopharma Buffer Market Size by Application
4.2.1 Global Biopharma Buffer Market Size Overview by Application (2018-2029)
4.2.2 Global Biopharma Buffer Historic Market Size Review by Application (2018-2024)
4.2.3 Global Biopharma Buffer Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Biopharma Buffer Sales Breakdown by Application (2018-2024)
4.3.2 Europe Biopharma Buffer Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Biopharma Buffer Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Biopharma Buffer Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Biopharma Buffer Sales Breakdown by Application (2018-2024)
5 North America Biopharma Buffer by Country
5.1 North America Biopharma Buffer Historic Market Size by Country
5.1.1 North America Biopharma Buffer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Biopharma Buffer Sales in Volume by Country (2018-2024)
5.1.3 North America Biopharma Buffer Sales in Value by Country (2018-2024)
5.2 North America Biopharma Buffer Forecasted Market Size by Country
5.2.1 North America Biopharma Buffer Sales in Volume by Country (2024-2029)
5.2.2 North America Biopharma Buffer Sales in Value by Country (2024-2029)
6 Europe Biopharma Buffer by Country
6.1 Europe Biopharma Buffer Historic Market Size by Country
6.1.1 Europe Biopharma Buffer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Biopharma Buffer Sales in Volume by Country (2018-2024)
6.1.3 Europe Biopharma Buffer Sales in Value by Country (2018-2024)
6.2 Europe Biopharma Buffer Forecasted Market Size by Country
6.2.1 Europe Biopharma Buffer Sales in Volume by Country (2024-2029)
6.2.2 Europe Biopharma Buffer Sales in Value by Country (2024-2029)
7 Asia-Pacific Biopharma Buffer by Region
7.1 Asia-Pacific Biopharma Buffer Historic Market Size by Region
7.1.1 Asia-Pacific Biopharma Buffer Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Biopharma Buffer Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Biopharma Buffer Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Biopharma Buffer Forecasted Market Size by Region
7.2.1 Asia-Pacific Biopharma Buffer Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Biopharma Buffer Sales in Value by Region (2024-2029)
8 Latin America Biopharma Buffer by Country
8.1 Latin America Biopharma Buffer Historic Market Size by Country
8.1.1 Latin America Biopharma Buffer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Biopharma Buffer Sales in Volume by Country (2018-2024)
8.1.3 Latin America Biopharma Buffer Sales in Value by Country (2018-2024)
8.2 Latin America Biopharma Buffer Forecasted Market Size by Country
8.2.1 Latin America Biopharma Buffer Sales in Volume by Country (2024-2029)
8.2.2 Latin America Biopharma Buffer Sales in Value by Country (2024-2029)
9 Middle East and Africa Biopharma Buffer by Country
9.1 Middle East and Africa Biopharma Buffer Historic Market Size by Country
9.1.1 Middle East and Africa Biopharma Buffer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Biopharma Buffer Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Biopharma Buffer Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Biopharma Buffer Forecasted Market Size by Country
9.2.1 Middle East and Africa Biopharma Buffer Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Biopharma Buffer Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Avantor
10.1.1 Avantor Company Information
10.1.2 Avantor Introduction and Business Overview
10.1.3 Avantor Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Avantor Biopharma Buffer Products Offered
10.1.5 Avantor Recent Development
10.2 Alfa Aesar (Thermo Fisher)
10.2.1 Alfa Aesar (Thermo Fisher) Company Information
10.2.2 Alfa Aesar (Thermo Fisher) Introduction and Business Overview
10.2.3 Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Alfa Aesar (Thermo Fisher) Biopharma Buffer Products Offered
10.2.5 Alfa Aesar (Thermo Fisher) Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Biopharma Buffer Products Offered
10.3.5 Merck Recent Development
10.4 Lonza
10.4.1 Lonza Company Information
10.4.2 Lonza Introduction and Business Overview
10.4.3 Lonza Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Lonza Biopharma Buffer Products Offered
10.4.5 Lonza Recent Development
10.5 Bio-Rad
10.5.1 Bio-Rad Company Information
10.5.2 Bio-Rad Introduction and Business Overview
10.5.3 Bio-Rad Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bio-Rad Biopharma Buffer Products Offered
10.5.5 Bio-Rad Recent Development
10.6 BD
10.6.1 BD Company Information
10.6.2 BD Introduction and Business Overview
10.6.3 BD Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.6.4 BD Biopharma Buffer Products Offered
10.6.5 BD Recent Development
10.7 GE Healthcare
10.7.1 GE Healthcare Company Information
10.7.2 GE Healthcare Introduction and Business Overview
10.7.3 GE Healthcare Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GE Healthcare Biopharma Buffer Products Offered
10.7.5 GE Healthcare Recent Development
10.8 Promega Corporation
10.8.1 Promega Corporation Company Information
10.8.2 Promega Corporation Introduction and Business Overview
10.8.3 Promega Corporation Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Promega Corporation Biopharma Buffer Products Offered
10.8.5 Promega Corporation Recent Development
10.9 Hamilton Company
10.9.1 Hamilton Company Company Information
10.9.2 Hamilton Company Introduction and Business Overview
10.9.3 Hamilton Company Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Hamilton Company Biopharma Buffer Products Offered
10.9.5 Hamilton Company Recent Development
10.10 XZL BIO-TECHNOLOGY
10.10.1 XZL BIO-TECHNOLOGY Company Information
10.10.2 XZL BIO-TECHNOLOGY Introduction and Business Overview
10.10.3 XZL BIO-TECHNOLOGY Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.10.4 XZL BIO-TECHNOLOGY Biopharma Buffer Products Offered
10.10.5 XZL BIO-TECHNOLOGY Recent Development
10.11 SRL
10.11.1 SRL Company Information
10.11.2 SRL Introduction and Business Overview
10.11.3 SRL Biopharma Buffer Sales, Revenue and Gross Margin (2018-2024)
10.11.4 SRL Biopharma Buffer Products Offered
10.11.5 SRL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biopharma Buffer Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biopharma Buffer Industrial Chain Analysis
11.4 Biopharma Buffer Market Dynamics
11.4.1 Biopharma Buffer Industry Trends
11.4.2 Biopharma Buffer Market Drivers
11.4.3 Biopharma Buffer Market Challenges
11.4.4 Biopharma Buffer Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biopharma Buffer Distributors
12.3 Biopharma Buffer Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Phosphates Type
Table 2. Major Company of Acetates Type
Table 3. Major Company of TRIS Type
Table 4. Major Company of Others
Table 5. Global Biopharma Buffer Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 7. Global Biopharma Buffer Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Biopharma Buffer Sales by Type (2018-2024) & (US& Million)
Table 9. Global Biopharma Buffer Market Share in Value by Type (2018-2024)
Table 10. Global Biopharma Buffer Price by Type (2018-2024) & (US$/L)
Table 11. Global Biopharma Buffer Sales by Type (2024-2029) & (KL)
Table 12. Global Biopharma Buffer Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Biopharma Buffer Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Biopharma Buffer Sales Market Share in Value by Type (2024-2029)
Table 15. Global Biopharma Buffer Price by Type (2024-2029) & (US$/L)
Table 16. North America Biopharma Buffer Sales by Type (2018-2024) & (KL)
Table 17. North America Biopharma Buffer Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Biopharma Buffer Sales (KL) by Type (2018-2024)
Table 19. Europe Biopharma Buffer Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Biopharma Buffer Sales (KL) by Type (2018-2024)
Table 21. Asia-Pacific Biopharma Buffer Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Biopharma Buffer Sales (KL) by Type (2018-2024)
Table 23. Latin America Biopharma Buffer Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Biopharma Buffer Sales (KL) by Type (2018-2024)
Table 25. Middle East and Africa Biopharma Buffer Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Biopharma Buffer Sales by Company (2018-2024) & (KL)
Table 27. Global Biopharma Buffer Sales Share by Company (2018-2024)
Table 28. Global Biopharma Buffer Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Biopharma Buffer Revenue Share by Company (2018-2024)
Table 30. Global Market Biopharma Buffer Price by Company (2018-2024) & (US$/L)
Table 31. Global Biopharma Buffer Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Biopharma Buffer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biopharma Buffer as of 2022)
Table 34. Date of Key Manufacturers Enter into Biopharma Buffer Market
Table 35. Key Manufacturers Biopharma Buffer Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Biopharma Buffer Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 39. Global Biopharma Buffer Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Biopharma Buffer Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Biopharma Buffer Sales Market Share in Value by Region (2018-2024)
Table 42. Global Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2018-2024)
Table 43. Global Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 44. Global Biopharma Buffer Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Biopharma Buffer Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Biopharma Buffer Sales Market Share in Value by Region (2024-2029)
Table 47. Global Biopharma Buffer Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2024-2029)
Table 48. Global Biopharma Buffer Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Biopharma Buffer Sales by Application (2018-2024) & (KL)
Table 50. Global Biopharma Buffer Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Biopharma Buffer Sales Market Share in Value by Application (2018-2024)
Table 53. Global Biopharma Buffer Price by Application (2018-2024) & (US$/L)
Table 54. Global Biopharma Buffer Sales by Application (2024-2029) & (KL)
Table 55. Global Biopharma Buffer Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Biopharma Buffer Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Biopharma Buffer Sales Market Share in Value by Application (2024-2029)
Table 58. Global Biopharma Buffer Price by Application (2024-2029) & (US$/L)
Table 59. North America Biopharma Buffer Sales by Application (2018-2024) (KL)
Table 60. North America Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Biopharma Buffer Sales by Application (2018-2024) (KL)
Table 62. Europe Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Biopharma Buffer Sales by Application (2018-2024) (KL)
Table 64. Asia-Pacific Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Biopharma Buffer Sales by Application (2018-2024) (KL)
Table 66. Latin America Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Biopharma Buffer Sales by Application (2018-2024) (KL)
Table 68. Middle East and Africa Biopharma Buffer Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 70. North America Biopharma Buffer Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Biopharma Buffer Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Biopharma Buffer Sales Market Share in Value by Country (2018-2024)
Table 73. North America Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 74. North America Biopharma Buffer Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Biopharma Buffer Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Biopharma Buffer Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 78. Europe Biopharma Buffer Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Biopharma Buffer Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Biopharma Buffer Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 82. Europe Biopharma Buffer Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Biopharma Buffer Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Biopharma Buffer Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Biopharma Buffer Sales by Region (2018-2024) & (KL)
Table 86. Asia-Pacific Biopharma Buffer Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Biopharma Buffer Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Biopharma Buffer Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Biopharma Buffer Sales by Region (2024-2029) & (KL)
Table 90. Asia-Pacific Biopharma Buffer Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Biopharma Buffer Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Biopharma Buffer Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 94. Latin America Biopharma Buffer Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Biopharma Buffer Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Biopharma Buffer Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 98. Latin America Biopharma Buffer Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Biopharma Buffer Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Biopharma Buffer Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Biopharma Buffer Sales by Country (2018-2024) & (KL)
Table 102. Middle East and Africa Biopharma Buffer Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Biopharma Buffer Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Biopharma Buffer Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Biopharma Buffer Sales by Country (2024-2029) & (KL)
Table 106. Middle East and Africa Biopharma Buffer Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Biopharma Buffer Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Biopharma Buffer Sales Market Share in Value by Country (2024-2029)
Table 109. Avantor Company Information
Table 110. Avantor Introduction and Business Overview
Table 111. Avantor Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 112. Avantor Biopharma Buffer Product
Table 113. Avantor Recent Development
Table 114. Alfa Aesar (Thermo Fisher) Company Information
Table 115. Alfa Aesar (Thermo Fisher) Introduction and Business Overview
Table 116. Alfa Aesar (Thermo Fisher) Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 117. Alfa Aesar (Thermo Fisher) Biopharma Buffer Product
Table 118. Alfa Aesar (Thermo Fisher) Recent Development
Table 119. Merck Company Information
Table 120. Merck Introduction and Business Overview
Table 121. Merck Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 122. Merck Biopharma Buffer Product
Table 123. Merck Recent Development
Table 124. Lonza Company Information
Table 125. Lonza Introduction and Business Overview
Table 126. Lonza Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 127. Lonza Biopharma Buffer Product
Table 128. Lonza Recent Development
Table 129. Bio-Rad Company Information
Table 130. Bio-Rad Introduction and Business Overview
Table 131. Bio-Rad Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 132. Bio-Rad Biopharma Buffer Product
Table 133. Bio-Rad Recent Development
Table 134. BD Company Information
Table 135. BD Introduction and Business Overview
Table 136. BD Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 137. BD Biopharma Buffer Product
Table 138. BD Recent Development
Table 139. GE Healthcare Company Information
Table 140. GE Healthcare Introduction and Business Overview
Table 141. GE Healthcare Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 142. GE Healthcare Biopharma Buffer Product
Table 143. GE Healthcare Recent Development
Table 144. Promega Corporation Company Information
Table 145. Promega Corporation Introduction and Business Overview
Table 146. Promega Corporation Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 147. Promega Corporation Biopharma Buffer Product
Table 148. Promega Corporation Recent Development
Table 149. Hamilton Company Company Information
Table 150. Hamilton Company Introduction and Business Overview
Table 151. Hamilton Company Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 152. Hamilton Company Biopharma Buffer Product
Table 153. Hamilton Company Recent Development
Table 154. XZL BIO-TECHNOLOGY Company Information
Table 155. XZL BIO-TECHNOLOGY Introduction and Business Overview
Table 156. XZL BIO-TECHNOLOGY Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 157. XZL BIO-TECHNOLOGY Biopharma Buffer Product
Table 158. XZL BIO-TECHNOLOGY Recent Development
Table 159. SRL Company Information
Table 160. SRL Introduction and Business Overview
Table 161. SRL Biopharma Buffer Sales (KL), Revenue (Million USD), Price (US$/L) and Gross Margin (2018-2024)
Table 162. SRL Biopharma Buffer Product
Table 163. SRL Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Biopharma Buffer Market Trends
Table 167. Biopharma Buffer Market Drivers
Table 168. Biopharma Buffer Market Challenges
Table 169. Biopharma Buffer Market Restraints
Table 170. Biopharma Buffer Distributors List
Table 171. Biopharma Buffer Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharma Buffer Product Picture
Figure 2. Global Biopharma Buffer Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biopharma Buffer Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Biopharma Buffer Sales Status and Outlook (2018-2029) & (KL)
Figure 5. Product Picture of Phosphates Type
Figure 6. Global Phosphates Type Sales YoY Growth (2018-2029) & (KL)
Figure 7. Product Picture of Acetates Type
Figure 8. Global Acetates Type Sales YoY Growth (2018-2029) & (KL)
Figure 9. Product Picture of TRIS Type
Figure 10. Global TRIS Type Sales YoY Growth (2018-2029) & (KL)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (KL)
Figure 13. Global Biopharma Buffer Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Biopharma Buffer Sales Market Share by Type in 2022 & 2029
Figure 15. North America Biopharma Buffer Sales Market Share in Volume by Type in 2022
Figure 16. North America Biopharma Buffer Sales Market Share in Value by Type in 2022
Figure 17. Europe Biopharma Buffer Sales Market Share in Volume by Type in 2022
Figure 18. Europe Biopharma Buffer Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Biopharma Buffer Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Biopharma Buffer Sales Market Share in Value by Type in 2022
Figure 21. Latin America Biopharma Buffer Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Biopharma Buffer Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Biopharma Buffer Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Biopharma Buffer Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharma Buffer Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharma Buffer Revenue in 2022
Figure 27. Biopharma Buffer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Research Institution
Figure 29. Global Research Institution Sales YoY Growth (2018-2029) & (KL)
Figure 30. Product Picture of Pharmaceutical Industry
Figure 31. Global Pharmaceutical Industry Sales YoY Growth (2018-2029) & (KL)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (KL)
Figure 34. Global Biopharma Buffer Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Biopharma Buffer Sales Market Share by Application in 2022 & 2029
Figure 36. North America Biopharma Buffer Sales Market Share in Volume by Application in 2022
Figure 37. North America Biopharma Buffer Sales Market Share in Value by Application in 2022
Figure 38. Europe Biopharma Buffer Sales Market Share in Volume by Application in 2022
Figure 39. Europe Biopharma Buffer Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Biopharma Buffer Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Biopharma Buffer Sales Market Share in Value by Application in 2022
Figure 42. Latin America Biopharma Buffer Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Biopharma Buffer Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Biopharma Buffer Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Biopharma Buffer Manufacturing Cost Structure
Figure 47. Biopharma Buffer Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries